Case Study

Case Study

Clinilabs Drug Development Corporation Achieves CNS Trial Startup in 1/3 the Time of Industry Standard
Case Study

A Double-Blind, Parallel Group, Randomized, Placebo Controlled Actigraphy Laboratory Study
Case Study

A Double-Blind, Parallel Group, Randomized, Placebo Controlled Sleep Laboratory Study
Case Study

Clinilabs’ Execution of Complex Phase 1 PK/PD Study Lays Foundation for New CNS Treatment
Case Study

Thrown a COVID Curveball, Clinilabs Swiftly Adapts Virtual DCT Approach for Sleep Study
Case Study

An Integrated Dose Escalation Study Evaluating the Safety, Tolerability, & Pharmacokinetics of a New Investigational Product in Healthy Volunteers
Case Study

A Randomized, Open-Label Study to Characterize the Pharmacokinetics and Safety of Multiple Doses of XXXX in Healthy Japanese and Non-Japanese Subjects
Case Study

Clinilabs Reduces Patient Outreach Time by 85%
Case Study

Lockstep Collaboration From Early Phase to NDA
Case Study

Clinilabs Puts Safety First in First-in-Human Trial, Designing Protocol to Mitigate Risk

When you need to get your product to the people who need it most, your pathway to CNS approval starts with Clinilabs.

Get in Touch